Page last updated: 2024-08-23

brimonidine tartrate and Allergic Contact Dermatitis

brimonidine tartrate has been researched along with Allergic Contact Dermatitis in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's4 (33.33)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Bourgault, S; Houle, MC; Lajoie, C; Ringuet, J; Simonyan, D1
Navarro-Triviño, FJ; Ruiz-Villaverde, R1
Castagliola, C; Fabbrocini, G; Napolitano, M; Patruno, C; Potestio, L1
Rajagopalan, A; Rajagopalan, B1
Cookson, H; McFadden, J; White, IR; White, J1
Bangsgaard, N; Fischer, LA; Zachariae, C1
Schmutz, JL1
Ratan, J; Sodhi, PK; Verma, L1
Bonini, S; Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M; Sacchetti, M1
Spaeth, GL1
Gross, RL; Orengo-Nania, S; Williams, GC1
Blondeau, P; Rousseau, JA1

Other Studies

12 other study(ies) available for brimonidine tartrate and Allergic Contact Dermatitis

ArticleYear
The benefit of scratch patch testing to demonstrate ocular contact allergy to brimonidine tartrate.
    Contact dermatitis, 2022, Volume: 87, Issue:4

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Humans; Patch Tests; Quinoxalines

2022
Periocular allergic contact dermatitis caused by brinzolamide.
    Contact dermatitis, 2021, Volume: 84, Issue:4

    Topics: Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Dermatitis, Allergic Contact; Drug Combinations; Facial Dermatoses; Female; Glaucoma; Humans; Middle Aged; Ophthalmic Solutions; Sulfonamides; Thiazines

2021
Allergic contact dermatitis probably due to brimonidine tartrate in eyedrops.
    Contact dermatitis, 2021, Volume: 85, Issue:3

    Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Humans; Male; Ophthalmic Solutions

2021
Allergic contact dermatitis to topical brimonidine.
    The Australasian journal of dermatology, 2015, Volume: 56, Issue:3

    Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Eruptions; Erythema; Facial Dermatoses; Humans; Male; Middle Aged

2015
Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.
    Contact dermatitis, 2015, Volume: 73, Issue:6

    Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Dermatologic Agents; Facial Dermatoses; Female; Gels; Humans; Rosacea; Young Adult

2015
Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
    Contact dermatitis, 2016, Volume: 74, Issue:6

    Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Facial Dermatoses; Humans; Male; Middle Aged; Rosacea

2016
[Allergic contact dermatitis to Mirvaso
    Annales de dermatologie et de venereologie, 2017, Volume: 144, Issue:1

    Topics: Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Glucocorticoids; Humans; Male; Middle Aged; Treatment Outcome

2017
Dermatological side effects of brimonidine: a report of three cases.
    The Journal of dermatology, 2003, Volume: 30, Issue:9

    Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Diagnosis, Differential; Facial Dermatoses; Female; Glaucoma, Open-Angle; Humans; Lichen Planus; Male; Nail Diseases; Ocular Hypertension; Ophthalmic Solutions; Patch Tests; Quinoxalines

2003
Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
    Journal of glaucoma, 2004, Volume: 13, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Demography; Dermatitis, Allergic Contact; Drug Hypersensitivity; Eyelid Diseases; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Risk Factors

2004
Allergic contact dermatitis caused by topical eye drops.
    American journal of ophthalmology, 2006, Volume: 142, Issue:4

    Topics: Administration, Topical; Antihypertensive Agents; Blepharitis; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines

2006
Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
    Journal of glaucoma, 2000, Volume: 9, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Clonidine; Conjunctivitis; Cross Reactions; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Hyperemia; Incidence; Male; Middle Aged; Quinoxalines; Retrospective Studies; Risk Factors

2000
Allergic reactions to brimonidine in patients treated for glaucoma.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2002, Volume: 37, Issue:1

    Topics: Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Levobunolol; Male; Quinoxalines; Retrospective Studies; Seasons

2002